Levetiracetam Tablet, Film Coated, Extended Release
Product Images NDC 71205-728

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 71205-728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levetiracetam 01)

Chemical Structure (Levetiracetam 01)
Chemical structure of levetiracetam, showing molecular bonds including a pyrrolidone ring, an amide group, and an ethyl side chain.*
FDA Label Image

Figure 1 (Levetiracetam 02)

Figure 1 (Levetiracetam 02)
A bar graph showing the percentage of patients by treatment group. The groups are placebo (n=96) with 7.4% of patients, immediate-release levetiracetam 1,000 mg/day (n=97) with 37.1%, and immediate-release levetiracetam 3,000 mg/day (n=101) with 39.6%. The y-axis represents the percentage of patients.*
FDA Label Image

Figure 2 (Levetiracetam 03)

Figure 2 (Levetiracetam 03)
A bar graph showing percentage of patients for three groups: placebo (N=111) at 6.3%, immediate-release levetiracetam 1,000 mg/day (N=106) at 20.8%, and immediate-release levetiracetam 2,000 mg/day (N=106) at 35.2%. The y-axis represents the percentage of patients, ranging from 0% to 45%. Each bar displays a percentage with an asterisk above the latter two groups.*
FDA Label Image

Figure 3 (Levetiracetam 04)

Figure 3 (Levetiracetam 04)
A bar graph comparing the percentage of patients between a placebo group (N=104) and an immediate-release levetiracetam group 3,000 mg/day (N=180). The placebo group shows 14.4% of patients, while the levetiracetam group shows 39.4%, with an asterisk indicating statistical significance.*
FDA Label Image

Figure 4 (Levetiracetam 05)

Figure 4 (Levetiracetam 05)
Bar chart comparing the percentage of patients between two groups: placebo (N=97) with 19.6% and immediate-release levetiracetam (N=101) with 44.6%. The vertical axis is labeled '% of Patients.'*
FDA Label Image

71205-728-30 (Levetiracetam 06)

71205-728-30 (Levetiracetam 06)
Levetiracetam 500 mg ER Tablets (Once Daily Dosing) label by Proficient Rx LP. The label indicates 30 film-coated, white oval-shaped tablets debossed with "SG" and "189". It includes the product ID QL072830 and states the manufacturer as ScieGen Pharmaceuticals, Inc., Hauppauge, NY. Storage instructions specify 20°-25°C (68°-77°F). The label features a barcode, a QR code, and multiple smaller printed panels with batch and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.